Research

Unleashing horsepower: The genetic secret behind equine stamina

Horses racing on track
The study reveals how a tiny “stop sign” in a key gene gets bypassed in horses, boosting their ability to generate energy. Photo by Mark Pearson.

LEXINGTON, Ky. (April 9, 2025)  A new study, supported by the University of Kentucky Martin-Gatton College of Agriculture, Food and Environment, has revealed a surprising genetic twist that may explain why horses are among the most powerful endurance athletes on the planet.

The research, published in the journal Science, reveals how a tiny “stop sign” in a key gene gets bypassed in horses, boosting their ability to generate energy and protect their muscles from damage during intense exercise.

The study titled “Running a genetic stop sign accelerates oxygen metabolism and energy production in horses” involved researchers from multiple institutions, led by scientists from Vanderbilt University, Johns Hopkins University and the University of Pennsylvania, with support from scientists at the UK Maxwell H. Gluck Equine Research Center.

“This discovery helps us understand the remarkable biology that makes horses such extraordinary athletes,” said Ted Kalbfleisch, a researcher on the study and professor in the Department of Veterinary Science. “For the last 40 years, we have written rules into software to predict what proteins would be produced given the genomes we have produced. Research findings like these reveal important ways we need to change those rules we are using.”

Running a genetic stop sign

In the study, researchers focused on a gene called KEAP1, known to control how cells sense and respond to stress. In most animals, this gene functions like a handbrake, regulating a cell’s built-in antioxidant and energy-regulating systems. When normal wear and tear or exercise causes stress, KEAP1 loosens its grip, letting cells make more protective molecules and more energy.

But in horses, and their close equid relatives like donkeys and zebras, the research team discovered that at a specific spot in KEAP1 there is a “stop” signal that generally tells the cell’s protein-making machinery to halt. In horses, that signal is ignored, so the gene produces a slightly altered version of the KEAP1 protein. Because of this change, horse cells end up dialing up their energy production and antioxidant defenses more than in other species.

Why does this matter? During running or other intense activities, cells burn oxygen to make energy, and that process can create harmful byproducts called “free radicals.” Over time, these byproducts damage tissues. In horses, however, this genetic quirk appears to give cells extra firepower: it increases production of the energy molecule ATP, while also enhancing the cell’s ability to neutralize free radicals.

This dual benefit — making energy faster while limiting damage — helps explain why horses can run longer and recover more swiftly than many other animals.

“Importantly, it also tells us there are a lot of interesting research questions we can ask based on the genomes of horses and other equids — for this case, areas of exercise physiology and sports medicine,” Kalbfleisch said.

Learning the details of this “stop sign” bypass in KEAP1 doesn’t just shed light on horse evolution and their superior athletic performance. It might also open doors to new therapies for conditions in which controlling harmful stress byproducts or boosting energy production is critical — both in veterinary and human medicine.

As the state’s flagship, land-grant institution, the University of Kentucky exists to advance the Commonwealth. We do that by preparing the next generation of leaders — placing students at the heart of everything we do — and transforming the lives of Kentuckians through education, research and creative work, service and health care. We pride ourselves on being a catalyst for breakthroughs and a force for healing, a place where ingenuity unfolds. It's all made possible by our people — visionaries, disruptors and pioneers — who make up 200 academic programs, a $476.5 million research and development enterprise and a world-class medical center, all on one campus.